dc.rights.license |
DOAJ Gold |
|
dc.date.accessioned |
2021-06-03T08:20:17Z |
|
dc.date.available |
2021-06-03T08:20:17Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
www.doi.org/10.1590/1806-9282.66.8.1122 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/95125 |
|
dc.description |
Bu yayın 06.11.1981 tarihli ve 17506 sayılı Resmî Gazete’de yayımlanan 2547 sayılı Yükseköğretim Kanunu’nun 4/c, 12/c, 42/c ve 42/d maddelerine dayalı 12/12/2019 tarih, 543 sayılı ve 05 numaralı Üniversite Senato Kararı ile hazırlanan Sakarya Üniversitesi Açık Bilim ve Açık Akademik Arşiv Yönergesi gereğince açık akademik arşiv sistemine açık erişim olarak yüklenmiştir. |
|
dc.description.abstract |
BACKGROUND: Easily accessible, inexpensive, and widely used laboratory tests that demonstrate the severity of COVID-19 are important. Therefore, in this study, we aimed to investigate the relationship between mortality in COVID-19 and platelet count, Mean Platelet Volume (MPV), and platelet distribution width. METHODS: In total, 215 COVID-19 patients were included in this study. The patients were divided into two groups. Patients with room air oxygen saturation < 90% were considered as severe COVID-19, and patients with >= 90% were considered moderate COVID-19. Patient medical records and the electronic patient data monitoring system were examined retrospectively. Analyses were performed using the SPSS statistical software. A p-value <0.05 was considered significant. RESULTS: The patients' mean age was 64,32 +/- 16,07 years. According to oxygen saturation, 81 patients had moderate and 134 had severe COVID-19. Our findings revealed that oxygen saturation at admission and the MPV difference between the first and third days of hospitalization were significant parameters in COVID-19 patients for predicting mortality. While mortality was 8.4 times higher in patients who had oxygen saturation under 90 % at hospital admission, 1 unit increase in MPV increased mortality 1.76 times. CONCLUSION: In addition to the lung capacity of patients, the mean platelet volume may be used as an auxiliary test in predicting the mortality in COVID-19 patients. |
|
dc.language |
English |
|
dc.language.iso |
İngilizce |
|
dc.publisher |
ASSOC MEDICA BRASILEIRA |
|
dc.relation.isversionof |
10.1590/1806-9282.66.8.1122 |
|
dc.rights |
info:eu-repo/semantics/openAccess |
|
dc.subject |
THROMBOCYTOPENIA |
|
dc.subject |
LYMPHOPENIA |
|
dc.subject |
INFECTIONS |
|
dc.subject |
Coronavirus Infections |
|
dc.subject |
Blood Platelets |
|
dc.subject |
Mean platelet volume |
|
dc.subject |
Mortality |
|
dc.title |
Effect of COVID-19 on platelet count and its indices |
|
dc.type |
Article |
|
dc.contributor.authorID |
kocayigit, havva/0000-0002-8719-7031 |
|
dc.contributor.authorID |
YURUMEZ, YUSUF/0000-0003-3917-9434 |
|
dc.contributor.authorID |
KARABAY, OGUZ/0000-0003-1514-1685 |
|
dc.contributor.authorID |
Erkorkmaz, Unal/0000-0002-8497-4704 |
|
dc.contributor.authorID |
YAYLACI, SELCUK/0000-0002-6768-7973 |
|
dc.identifier.volume |
66 |
|
dc.identifier.startpage |
1122 |
|
dc.identifier.endpage |
1127 |
|
dc.relation.journal |
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA |
|
dc.identifier.issue |
8 |
|
dc.identifier.wos |
WOS:000568954700017 |
|
dc.identifier.doi |
10.1590/1806-9282.66.8.1122 |
|
dc.identifier.eissn |
1806-9282 |
|
dc.contributor.author |
Guclu, Ertugrul |
|
dc.contributor.author |
Kocayigit, Havva |
|
dc.contributor.author |
Okan, Huseyin Dogus |
|
dc.contributor.author |
Erkorkmaz, Unal |
|
dc.contributor.author |
Yurumez, Yusuf |
|
dc.contributor.author |
Yaylaci, Selcuk |
|
dc.contributor.author |
Koroglu, Mehmet |
|
dc.contributor.author |
Uzun, Cem |
|
dc.contributor.author |
Karabay, Oguz |
|
dc.relation.publicationcategory |
Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı |
|
dc.identifier.pmıd |
32935808 |
|